(lp0
S"Stock Returns: Enanta Pharmaceuticals Inc  versus Sangamo ... CML News - Apr 17, 2017 This is a snapshot to compare the stock returns for Enanta Pharmaceuticals Inc  versus Sangamo Therapeutics Inc  .Enanta Pharmaceuticals Inc  Position Reduced by Envestnet Asset ... - The Cerbat GemEnanta Pharmaceuticals, Inc.'s  stock price ends Thursday with change of ... - Hot Stocks Point"
p1
aS'Enanta Pharmaceuticals Inc. ENTA  Wall Street Journal - Mar 22, 2013 ... Enanta Pharmaceuticals Inc.ENTA. Significant News Only. 04/05/17; Press Release. Enanta Pharmaceuticals Announces Data Presentations at The International Liver Congress 2017.'
p2
aS'Enanta Pharmaceuticals, Inc. Common Stock Quote &amp; Summary Data Nasdaq - Nov 8, 2012 We are a research and development-focused biotechnology company that uses our robust, chemistry-driven approach and drug discovery capabilities to create small molecule drugs primarily for the treatment of viral infections and liver diseases.'
p3
aS'30.69 MarketWatch - Mar 25, 2013 Enanta Pharmaceuticals Inc. Watchlist CreateENTAAlert. After Hours. Last Updated: Apr 13, 2017 4:32 p.m.. $ 30.69.'
p4
aS'Why Enanta Pharmaceuticals Inc. Shares Shot Higher Motley Fool - Dec 10, 2013 What: Shares of Enanta Pharmaceuticals , a small-molecule drug developer targeted at infectious disease, soared as much as 20% after clinical partner AbbVie  reported positive results from its second phase 3 trial of six&nbsp;...AbbVie oral hep C drugs cure 96 percent in late stage trial - Reuters'
p5
aS"Enanta Pharmaceuticals Announces Data Presentations at The International Liver ... Yahoo Finance - Apr 5, 2017 Enanta Pharmaceuticals, Inc. , a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that several abstracts regarding Enanta's&nbsp;..."
p6
aS'Enanta Pharmaceuticals: Buy It For The HCV Business, And Get The NASH For Free Seeking Alpha - Oct 11, 2016 Enanta Pharmaceuticals Inc.  is a pharmaceutical development company focused on virology and liver disease. It has developed and commercialized, with strategic partner AbbVie , three waves of Hepatitis C  treatments.'
p7
aS'Enanta Pharmaceuticals to Present at the HC Wainwright 1st Annual NASH ... Yahoo Finance - Mar 27, 2017 Enanta Pharmaceuticals, Inc. , a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.'
p8
aS"Enanta: Half Cash, All Upside Seeking Alpha - Feb 28, 2017 Investors have likely been disappointed in the past year and three years, but the company's early stage pipeline could breathe new life into shares."
p9
aS'Enanta: Robust Balance Sheet With Numerous Catalysts Seeking Alpha - Oct 31, 2016 Enanta Pharmaceuticals  is a small-cap pharmaceutical company focused on liver diseases such as hepatitis C  and Nonalcoholic Steatohepatitis .'
p10
a.